Case ID: f-appx_594/html/0686-01.html
Source: Caselaw Access Project
Author: {"author": "PER CURIAM.", "license": "Public Domain", "url": "https://static.case.law/"}
Date Created: 2024-08-24T03:29:51.129683

VIIV HEALTHCARE UK LTD., VIIV Healthcare Co., Plaintiffs-Cross-Appellants v. LUPIN LTD., Lupin Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., Defendants-Appellants
    Nos. 2014-1303, 2014-1304, 2014-1315.
    United States Court of Appeals, Federal Circuit.
    Feb. 12, 2015.
    John O’Quinn, Kirkland & Ellis LLP, Washington, DC, argued for plaintiff-cross-appellants. Also represented by Francis Christopher Mizzo, William H. Burgess, Craig Thomas Murray.
    Deanne M. Mazzochi, Rakoczy Molino Mazzochi Siwik LLP, Chicago, IL, argued for defendant-appellants Lupin, Ltd., Lu-pin Pharmaceuticals, Inc. Also represented by William A. Rakoczy, Paul J. Molino, Rachel Waldron, Patrick C. Kilgore.
    Henry C. Dinger, Goodwin Procter LLP, Boston, MA, argued for defendant-appellant Teva Pharmaceuticals USA, Inc. Also represented by Ira J. Levy, David M. Hashmall, Joshua Aaron Whitehill, New York, NY; William M. Jay, Washington, DC.
    PROST, Chief Judge, MOORE and O’MALLEY, Circuit Judges.
   JUDGMENT

PER CURIAM.

This Cause having been heard and considered, it is

Ordered and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.